Additional information
White Powder
945553-91-3
ACI-015513
125.9-129.0°C
C24H25ClFN5O3
485.94
Ambient
2-8°C
Antineoplastic
Pharmaceutical Impurity Standards
(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinozolin- 6-yl)-4-(dimethylamino)but-2-enamide
(R,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetra hydrofuran-3-yl)oxy)quinozolin-6-yl)-4-(dimethylamino)but-2-enamide
ent-Afatinib





![N-METHYL REGADENOSON (25 mg) (1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N,N-dimethylpyrazole-4-carboxamide )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)